Le Sebi s'apprête à introduire des ETF obligataires et des produits dérivés

Le Securities and Exchange Board of India prévoit de lancer des fonds négociés en bourse (ETF) obligataires et des produits dérivés visant à renforcer le marché de la dette d'entreprise.

Le régulateur réexaminera également les exigences de cotation pour les entreprises qui émettent uniquement des titres de créance. Il étudie un projet pilote de tokenisation des obligations d'entreprise, dans le but d'améliorer la liquidité et d'élargir l'accès aux investisseurs.

Articles connexes

Illustration of SEC building with crypto and stock elements for tokenized trading news.
Image générée par IA

Sec plans exemption for tokenized stock trading

Rapporté par l'IA Image générée par IA

The Securities and Exchange Commission is expected to release an innovation exemption for tokenized stocks as soon as this week. The move would allow equities to trade through crypto-native infrastructure such as automated market makers and stablecoins.

India's markets regulator Sebi has proposed relaxing securitisation norms to match Reserve Bank of India regulations. The changes include easing the 25% single borrower exposure cap and shifting disclosure duties to servicers.

Rapporté par l'IA

The National Stock Exchange has filed its draft prospectus with SEBI. This step advances its planned Initial Public Offering, expected to reach around ₹30,000 crore.

Starting September 1, 2026, SEBI will permit mutual funds to use intraday borrowing to address short-term liquidity mismatches during payouts.

Rapporté par l'IA

Foreign portfolio investors are directing record amounts into India's government securities this month following recent policy adjustments.

Foreign portfolio investors have injected nearly ₹10,000 crore into Indian bonds over four trading sessions. The inflows reversed recent outflows from the debt market.

Rapporté par l'IA

Two Indian companies have secured regulatory clearance to proceed with initial public offerings. Deepa Jewellers and Cotec Healthcare both obtained approval from the Securities and Exchange Board of India.

 

 

 

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser